Ana Cristina Rego
Portuguese neuroscientist
- 2 min read
- 2 chapters
Related on Lably
Through Alzheimer's disease, Cell biology and Academic tenure
Training
Ana Cristina Carvalho Rego obtained a master's degree in cell biology in 1994 and a PhD in cell biology in January 1999 from the University of Coimbra, under the supervision of Prof. Catarina Resende de Oliveira.
Sign in to keep reading
One more chapter is free with a Lably account.
Career
Rego began work in 1997 as a teaching assistant at the Faculty of Medicine of the University of Coimbra (FMUC). After obtaining her doctorate, she became an assistant professor in 1999, receiving tenure in 2004 and Aggregation (Agregação) in 2010. She became an associate professor in 2019, teaching classes in biochemistry, neuroscience and neurobiology at the Centre for Neuroscience and Cell Biology (CNC) at the university. During the period 1998-2000 she was also a post-doctoral researcher in the laboratory of Prof. David G. Nicholls, at the University of Dundee in Scotland and visiting researcher at the David Nicholls Lab of the Buck Institute for Research on Aging, in Novato, California.
Rego's research group at CNC aims to understand fundamental cell and molecular mechanisms in early/initial stages of brain neurodegenerative disorders including Huntington's, Parkinson's and Alzheimer's diseases, for which there is still no cure. The initial steps of neuronal dysfunction, occurring before the main disease-related symptoms, are still not completely understood. To address these issues, she has obtained funding from the CHDI Foundation (USA), the Lundbeck Foundation, the Fundação para a Ciência e a Tecnologia (Foundation for Science and Technology-FCT), which is the Portuguese state body that awards grants for scientific research, and from the European Huntington's Disease Network. She became president of the Portuguese Society for Neuroscience in 2019 and is vice-president of the Portuguese Brain Council. She is a reviewer for funding bodies, including Parkinson's UK, Alzheimer's Research UK, the Austrian Science Fund, Agence nationale de la recherche in France, the Israel Science Foundation, the Wellcome Trust and the Alzheimer's Association.